MILESTONE

THE GROWTH OF APTORUM

2018
  • Acticule officially launched, remarked the expansion of business coverage into infectious disease.
  • Issued USD15 million convertible bond to Peace Range Limited, a wholly-owned special purpose vehicle of Adamas Ping An Opportunities Fund L.P., which is the third fund from Adamas Asset Management (HK) Limited and the first fund from the joint venture between Adamas and Yun Sheng Capital Company Limited, a subsidiary of Ping An Insurance (Group) Company of China, Limited and is advised by Ping An Capital Company Limited.
  • Issued Series A Notes of USD1.6 million.
  • Developed our first R&D Center in Science Park, Hong Kong.
  • Further purchased another property for the development of our 2nd R&D center.
  • Launched Talem Medical, our first medical center.
  • Closed our Initial Public Offering and commenced trading on The NASDAQ Global Market on December 18, 2018 under the ticker symbol “APM.”
2017
  • Incorporated Videns and highlighted an important footprint into neurology.
  • Obtained a total of 11 licensed therapeutic technologies as of December 31, 2017.
2016
  • Obtained the 1st licensed therapeutic technology.
×
Terms of Use

This Website contains information concerning Aptorum Group Limited (“Aptorum Group”) and its affiliates that may be useful to Aptorum Group’s customers, suppliers, employees, directors and shareholders, as well as members of the general public. However, by using this Website you are accepting all of the terms of this disclaimer notice, including exclusions and limitations of liability. If you do not agree with anything in this notice, you should not use this Website.

Aptorum Group does not claim ownership of the materials and product images on the Website that are provided to us by our third party suppliers.

Where our Website contains links to other sites and resources provided by third parties, these links are provided for your information only. We have no control over the contents of those sites or resources, and accept no responsibility for them or for any loss or damage that may arise from your use of them. These links are provided solely as a convenience to you and not as an endorsement by us of the contents on such third party websites.

While reasonable efforts are made to ensure that the contents of this Website are accurate, this Website and its contents are provided on an “as is,” “as available” basis, without warranties of any kind, including any warranty that the Website will be kept up to date, be true and not misleading, or that the Website will always (or ever) be available for use. Aptorum Group and its affiliates disclaim all warranties, express or implied, with respect to the Website and its contents, including, without limitation, any warranties of accuracy, completeness, timeliness, non-infringement, title, merchantability, or fitness for a particular purpose. Because some jurisdictions do not permit the exclusion of certain warranties, these exclusions may not apply to you.

In no event will Aptorum Group or its affiliates be liable for any incidental, indirect, consequential, or special damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of profits, contracts, goodwill, data, information, income, anticipated savings, or business relationships, whether or not Aptorum Group or its affiliates have been advised of the possibility of such damage, arising out of or in connection with the use of this Website or its contents or any other sites linked to this Website.

If you have any concerns about material which appears on our Website, please contact us. We have the right and the ability to remove immediately from our Website any material that is infringing, defamatory, offensive, abusive, harming, deceptive, threatening or otherwise illegal.